IRCT20210206050268N1
Recruiting
Phase 3
Evaluation and comparison of the effect of premedication (Methylprednisolone and Naproxen) with placebo in controlling acute complications of IVIG injection in patients with a diagnosis of neurological disease
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- premedication use for intravenous immunoglobulin administration.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with a diagnosis of neurological disease, including myasthenia gravis, Guillain\-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), etc., who are candidates for IVIG will be included in the study.
Exclusion Criteria
- •The patient's unwillingness to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
The effect of preoperative use of celecoxib , gabapentin , combination of celecoxib with gabapantin and combination of celecoxib with dexamethasone and gabapantin on postoperative pain reliefTotal Knee Arthroplasty.Sarcoid arthropathyD86.86IRCT20200217046523N10Esfahan University of Medical Sciences144
Completed
Not Applicable
Comparison between two different drugs used in increasing blood pressure after spinal anaesthesia for caesarean section surgeriesCTRI/2018/03/012866Amit Vikram Das112
Completed
Phase 4
Comparison of the effects of Pregabalin, Dexmedetomidine, and their combination on the haemodynamic response and anaesthetic requirementsHealth Condition 1: null- ASA Grade 1 and 2CTRI/2017/09/009862VMMC and Safdarjung Hospital90
Recruiting
Phase 3
Effects of treatment with premarin and clobetasol-premarin in vaginal disease after hematopoietic stem cell transplantation.IRCT20160615028486N3Tehran University of Medical Sciences55
Not yet recruiting
Not Applicable
â??A COMPARATIVE STUDY TO ASSESS THE EFFECT OF ANTIDEPRESSANT AND ANTICONVULSANT MEDICATION IN PATIENTS SUFFERING FROM PRIMARY KNEE OSTEOARTHRITISHealth Condition 1: M170- Bilateral primary osteoarthritis of kneeCTRI/2023/05/052848Department of Rheumatology